Molecular mechanism of XB130 adaptor protein mediates trastuzumab resistance in gastric cancer.
Shengnan YangBinbin WangJiaqi LiaoZiyang HongXuxian ZhongSuling ChenZiqing WuXingyu ZhangQiang ZuoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
In HER2 + GC, XB130 contributes to trastuzumab resistance by stimulating the PI3K/AKT signaling pathway through binding to PI3K p85α under the mediation of SRC kinase and regulating PTEN gene transcription, and in turn forming a positive feedback loop between SRC-XB130-PTEN.